Truist Financial
DGX icon

Truist Financial’s Quest Diagnostics DGX Stock Holding History

Truist Financial’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.29M Sell
29,668
-1,706
-5% -$335K 0.01% 810
2026
Q1 		$6.15M Sell
31,374
-3,428
-10% -$666K 0.01% 777
2025
Q4 		$6.04M Sell
34,802
-8,740
-20% -$1.59M 0.01% 777
2025
Q3 		$8.3M Sell
43,542
-10,432
-19% -$1.85M 0.01% 679
2025
Q2 		$9.7M Sell
53,974
-1,298
-2% -$225K 0.01% 595
2025
Q1 		$9.35M Buy
55,272
+34,148
+162% +$5.61M 0.02% 586
2024
Q4 		$3.19M Buy
21,124
+213
+1% +$33.1K 0.01% 1026
2024
Q3 		$3.25M Buy
20,911
+1,617
+8% +$241K 0.01% 1019
2024
Q2 		$2.64M Sell
19,294
-1,372
-7% -$188K ﹤0.01% 1148
2024
Q1 		$2.75M Buy
20,666
+4,407
+27% +$572K ﹤0.01% 1134
2023
Q4 		$2.24M Buy
16,259
+2,640
+19% +$347K ﹤0.01% 1202
2023
Q3 		$1.66M Sell
13,619
-4,457
-25% -$594K ﹤0.01% 1324
2023
Q2 		$2.54M Sell
18,076
-5,383
-23% -$742K ﹤0.01% 1145
2023
Q1 		$3.32M Buy
23,459
+494
+2% +$70.7K 0.01% 998
2022
Q4 		$3.59M Buy
22,965
+4,157
+22% +$597K 0.01% 939
2022
Q3 		$2.31M Sell
18,808
-955
-5% -$126K ﹤0.01% 1095
2022
Q2 		$2.63M Sell
19,763
-2,426
-11% -$331K ﹤0.01% 1089
2022
Q1 		$3.04M Buy
22,189
+178
+0.8% +$24.8K ﹤0.01% 1096
2021
Q4 		$3.81M Buy
22,011
+7,624
+53% +$1.16M 0.01% 996
2021
Q3 		$2.09M Buy
14,387
+1,881
+15% +$275K ﹤0.01% 1251
2021
Q2 		$1.65M Sell
12,506
-8,615
-41% -$1.13M ﹤0.01% 1387
2021
Q1 		$2.71M Sell
21,121
-65,398
-76% -$8.06M ﹤0.01% 1102
2020
Q4 		$10.3M Buy
86,519
+66,361
+329% +$8.09M 0.02% 594
2020
Q3 		$2.31M Buy
20,158
+20,094
+31,397% +$2.37M 0.01% 1022
2020
Q2 		$7K Sell
64
-48,474
-100% -$5.14M ﹤0.01% 2393
2020
Q1 		$3.9M Buy
48,538
+31,661
+188% +$3.28M 0.01% 741
2019
Q4 		$1.8M Buy
+16,877
New +$1.76M ﹤0.01% 1178
2018
Q4 		– Sell
-2,520
Closed -$272K – 765
2018
Q3 		$272K Sell
2,520
-308
-11% -$33.8K ﹤0.01% 700
2018
Q2 		$311K Sell
2,828
-1,192
-30% -$124K 0.01% 670
2018
Q1 		$403K Sell
4,020
-4,121
-51% -$422K 0.01% 605
2017
Q4 		$802K Sell
8,141
-1,637
-17% -$155K 0.02% 504
2017
Q3 		$916K Sell
9,778
-495
-5% -$52.5K 0.02% 480
2017
Q2 		$1.14M Sell
10,273
-445
-4% -$47.1K 0.02% 452
2017
Q1 		$1.05M Sell
10,718
-4,544
-30% -$433K 0.02% 462
2016
Q4 		$1.4M Sell
15,262
-1,141
-7% -$98.3K 0.03% 415
2016
Q3 		$1.39M Sell
16,403
-1,089
-6% -$91.5K 0.03% 418
2016
Q2 		$1.42M Buy
17,492
+3,744
+27% +$285K 0.03% 422
2016
Q1 		$982K Sell
13,748
-122
-0.9% -$8.18K 0.03% 432
2015
Q4 		$986K Buy
13,870
+4,152
+43% +$279K 0.03% 419
2015
Q3 		$597K Buy
9,718
+3,424
+54% +$239K 0.02% 517
2015
Q2 		$456K Buy
6,294
+2,520
+67% +$186K 0.01% 558
2015
Q1 		$290K Buy
3,774
+593
+19% +$42.5K 0.01% 677
2014
Q4 		$213K Buy
+3,181
New +$201K 0.01% 741

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial's DGX Position: Q2 2026 in Review

Truist Financial reduced its Quest Diagnostics (DGX) stake by 5.4% in Q2 2026, selling an estimated $335K and leaving 29,668 shares worth $6.29M. The position accounts for 0.01% of the portfolio, ranked #810.

Truist Financial first reported a position in DGX in Q4 2014 and has held it in 43 quarters since. The position peaked at $10.3M in Q4 2020. 444 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Truist Financial held 29,668 shares of Quest Diagnostics worth $6.29M as of Q2 2026.
  • Truist Financial sold 1,706 Quest Diagnostics shares in Q2 2026, an estimated $335K.
  • Quest Diagnostics made up 0.01% of Truist Financial's portfolio in Q2 2026, its #810 holding.
  • Truist Financial first reported a position in Quest Diagnostics in Q4 2014 and has held it in 43 quarters since.
  • Truist Financial's Quest Diagnostics position peaked at $10.3M in Q4 2020.
  • 444 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.